-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAP-0971 in Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAP-0971 in Lung Cancer Drug Details: IAP-0971 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAP-0971 in Cervical Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAP-0971 in Cervical Cancer Drug Details: IAP-0971 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAP-0971 in Liver Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAP-0971 in Liver Cancer Drug Details: IAP-0971 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IBB-0979 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IBB-0979 in Solid Tumor Drug Details: IBB-0979 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAE-0972 in Cutaneous Squamous Cell Carcinoma (cSCC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAE-0972 in Cutaneous Squamous Cell Carcinoma (cSCC) Drug Details: IAE-0972 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAP-0971 in Head And Neck Squamous Cell Carcinoma (HNSC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAP-0971 in Head And Neck Squamous Cell Carcinoma (HNSC) Drug Details: IAP-0971 is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAP-0971 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAP-0971 in Solid Tumor Drug Details: IAP-0971 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAP-0971 in Non-Hodgkin Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAP-0971 in Non-Hodgkin Lymphoma Drug Details: IAP-0971 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAE-0972 in Squamous Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAE-0972 in Squamous Non-Small Cell Lung Cancer Drug Details: IAE-0972 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IAP-0971 in Head And Neck Cancer Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. IAP-0971 in Head And Neck Cancer Squamous Cell Carcinoma Drug Details: IAP-0971 is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pritelivir in Simplexvirus (HSV) Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Pritelivir in Simplexvirus (HSV) Infections Drug Details:Pritelivir (AIC-316, BAY-571293) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pritelivir in Herpes Labialis (Oral Herpes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Pritelivir in Herpes Labialis (Oral Herpes) Drug Details:Pritelivir (AIC-316, BAY-571293) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pritelivir in Genital Herpes
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Pritelivir in Genital Herpes Drug Details:Pritelivir (AIC-316, BAY-571293) is under development for the treatment of genital...
-
Product Insights
New![]()
Eloise Mine
The Eloise Mine is a copper mine in Australia. It is currently in operation. Empower your strategies with our Eloise Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...
-
Product Insights
![]()
Aic Metaliks – Jamuria Pellet Plant Expansion – West Bengal
Equip yourself with the essential tools needed to make informed and profitable decisions with our Aic Metaliks - Jamuria Pellet Plant Expansion - West Bengal report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
AIC Hotel – 8800 Meadow Creek Drive Water Park – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our AIC Hotel - 8800 Meadow Creek Drive Water Park - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Track & Monitor
![]()
Artificial Intelligence in Healthcare: Digital Pathology
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Company Profile
![]()
AIC Mines Ltd – Company Profile
AIC Mines Ltd (AIC Mines), formerly Intrepid Mines Ltd, is a mining company that explores and develops mining projects in Australia. The company primarily operates through two projects as The Lamil Project and the Marymia Project. It owns 50% of The Lamil Project, and 100% of The Marymia Project. The Lamil Project, which is located in Paterson Province in Western Australia has and started a joint venture between Rumble Resources. The Marymia Project is located approximately 160km south of Newman...
Add to Basket -
Sector Analysis
![]()
India General Insurance Market Size and Trends by Line of Business, Distribution, Competitive Landscape and Forecast to 2027
India General Insurance Market Report Overview The gross written premium of the India general insurance market was INR2.7 trillion in 2022 and is expected to achieve a CAGR of more than 8% during 2023-2027. The India general insurance market research report provides in-depth market analysis, information, and insights into the India’s general insurance segment. It also provides values for key performance indicators such as gross written premium, loss ratio, retail, and commercial split, premium by line of business, and reinsurance...
-
Product Insights
![]()
Hemodynamic Support Devices – Abiomed Inc – IMPELLA AIC
GlobalData, the industry analysis specialist, has released its latest report: Hemodynamic Support Devices - Abiomed Inc - IMPELLA AIC. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.